Lv3
280 积分 2023-08-16 加入
Epithelial alarmins: a new target to treat chronic respiratory diseases
3天前
已完结
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study
16天前
已完结
Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort
16天前
已完结
Role of Monoclonal Antibodies in the Management of Eosinophilic COPD: A Meta-analysis of Randomized Controlled Trials
16天前
已关闭
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial
23天前
已完结
Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD
24天前
已完结
Smaller Differences in the Comparative Effectiveness of Biologics in Reducing Asthma-Related Hospitalizations Compared With Overall Exacerbations
24天前
已完结
Comparative Impact of Asthma Biologics: A Nationwide US Claim-Based Analysis
24天前
已关闭
Role of Monoclonal Antibodies in the Management of Eosinophilic COPD: A Meta-analysis of Randomized Controlled Trials
25天前
已关闭
Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
1个月前
已完结
皖公网安备34019202002308
